The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $81.3723 to $82.3267, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.20 to $83.9902, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range set forth in this footnote.

/s/ Jordan Frankel, Attorney-in-Fact for Jared Isaacman


Martin Product Sales LLC ("Martin Product"), is a wholly owned subsidiary of Martin Resource Management Corporation ("MRMC"), and therefore, MRMC may be deemed to beneficially own the common units (the "Common Units") representing limited partner interests in Martin Midstream Partners L.P. (the "Partnership") held by Martin Product. Following the transaction, MRMC will directly or indirectly own 7,662,005.23 Common Units, including the Common Units directly held by Martin Product, and has control of the general partner of the Partnership by virtue of its owning 100% of the equity interests of the sole member of the Partnership's general partner.

/s/ Sharon L. Taylor, Executive Vice President and Chief Financial Officer


Trustee of Martin Tuchman Revocable Trust

Martin Tuchman, by Edward Hogan, attorney-in-fact


The Reporting Person disclaims beneficial ownership of the shares held by her son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of her son's shares for purposes of Section 16 or for any other purpose.


This transaction was executed in multiple trades at prices ranging from $11.61 to $11.65.  The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Includes 80,990 unvested shares of restricted stock.


Common Stock

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

The transaction(s) reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

3.33% of the shares subject to the restricted stock units vested on each of May 7, 2024, and August 7, 2024, 3.34% of the shares subject to the restricted stock units vested on November 7, 2024, and the remaining 90% of the shares subject to the restricted stock units will vest quarterly beginning on February 7, 2025, and subject to the reporting person's continued service to the Issuer on each vesting date.

/s/ Jacqueline P. Canney by Russell S. Elmer, Attorney-in-Fact


Common Stock

Non-Qualified Stock Option (right to buy)

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on August 7, 2025, and are reported herein.

Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (August 7, 2023), respectively.


Common Stock


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Includes 6 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2025.

30% of the shares subject to the restricted stock units vested on February 7, 2025, 15% of the shares subject to the restricted stock units vested on August 7, 2025. 15% of the shares subject to the restricted stock units will vest on February 7, 2026, and 20% of the shares subject to the restricted stock units will vest on each of August 7, 2026, and February 7, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.

Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 15, 2024 under the Issuer's 2021 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2024 until December 31, 2024, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on February 4, 2025.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on May 7, 2024, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting having occurred on November 7, 2024, and subject to the Reporting Person's continued service to the Issuer on each vesting date.

/s/ Paul Fipps by Russell S. Elmer, Attorney-in-Fact


Common Stock

Each restricted stock unit (RSU) is granted pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated Long-Term 2021 Incentive Plan and represents a contingent right to receive one share of BW common stock.

RSUs vest in three annual installments beginning August 7, 2026.

/s/ John J. Dziewisz, attorney-in-fact for Kenneth M. Young


Common Stock

Includes 15 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2025.

The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2024.

/s/ Gina Mastantuono by Russell S. Elmer, Attorney-in-Fact


Common Stock

Common Stock

Common Stock

Includes 8 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2025.

Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.

Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2024, as determined by the Compensation Committee on February 7, 2025. 30% of the shares subject to the RSUs vested on February 7, 2025, and 15% of the shares subject to the RSUs vested on August 7, 2025. The remaining shares subject to the RSUs will vest as follows: 15% on February 7, 2026, 20% on August 7, 2026, and 20% on February 7, 2027, provided the reporting person is employed by or is providing services to the Issuer on each applicable vesting date.

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock

29.17% of the shares subject to the restricted stock units vested on February 7, 2023, and the remaining restricted stock units vest in equal quarterly installments over three (3) years (with the final vest prorated), and subject to the continued service of the Reporting Person on each vesting date.

/s/ Kevin Thomas McBride by Russell S. Elmer, Attorney-in-Fact


Common Stock

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

3.33% of the shares subject to the restricted stock units vested on each of May 7, 2024, and August 7, 2024, 3.34% of the shares subject to the restricted stock units will vest on November 7, 2024, and the remaining 90% of the shares subject to the restricted stock units will vest quarterly beginning on February 7, 2025, and subject to the reporting person's continued service to the Issuer on each vesting date.

/s/ William R. McDermott by Russell S. Elmer, Attorney-in-Fact


Common Stock

/s/ Nicholas Tzitzon by Russell S. Elmer, Attorney-in-Fact


Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by "sell to cover" transactions and does not represent a discretionary transaction by the Reporting Person.

The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $2.28 to $2.73, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.

/s/ Benjamin G. Jackson, Attorney-in-fact


Common Stock

/s/ John J. Dziewisz, attorney-in-fact for Jimmy B. Morgan


Common Stock

16.75% of the shares subject to the restricted stock units vested on each of February 7, 2025, May 7, 2025, and August 7, 2025, 16.75% will vest on November 7, 2025, and the remaining 33% of the shares subject to the restricted stock units will vest quarterly beginning on February 7, 2026, and subject to the reporting person's continued service to the Issuer on each vesting date.

/s/ Amit Zavery by Russell S. Elmer, Attorney-in-Fact


Commn Stock

The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 13, 2025.

Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.


Effective at the close of business on August 7, 2025, the reporting person no longer serves as Co-Chief Executive Officer and Co-President of Phillip Street Middle Market Lending Fund LLC.


Common Stock

Each Restricted Stock Unit ("RSU") represents a contingent right to receive, either (i) one share of GXO Logistics, Inc. ("GXO") common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock.

These RSUs vest in three equal annual installments on August 8, 2026, August 8, 2027, and August 8, 2028,  subject to the Reporting Person's continued employment with GXO.


LP interests in RPI US Partners 2019, LP

Class A Ordinary Shares

These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with the exchange.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.40 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value.

/s/ Sean Weisberg, as Attorney-in-Fact for Gregory Norden


The reported securities are represented by restricted stock units ("RSUs").  Pursuant to the terms of the RSU, 25% of the total number of shares underlying the RSU shall vest on August 7, 2026, and 1/16th of the total number of shares underlying the RSU shall vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

/s/ Jeffrey Adam Novack, Attorney-in-Fact


Common Stock

Each restricted stock unit (RSU) is granted pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated Long-Term 2021 Incentive Plan and represents a contingent right to receive one share of BW common stock.

RSUs vest in three annual installments beginning August 7, 2026.

/s/ John J. Dziewisz, Attorney-in-Fact for Cameron M. Frymyer


Effective at the close of business on August 7, 2025, the reporting person no longer serves as Co-Chief Executive Officer and Co-President of Silver Capital Holdings LLC.


Effective at the close of business on August 7, 2025, the reporting person no longer serves as Co-Chief Executive Officer and Co-President of West Bay BDC LLC.


Common Stock

The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.


The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.25 to $29.00. The reporting person undertakes to provide to Global Indemnity Group, LLC, any security holder of Global Indemnity Group, LLC, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

Includes 1,172,319 A Common Shares held by Mercury Assets Delaware LLC and Common Shares owned indirectly by Mercury Assets Delaware LLC through its limited partnership interest in Fox Mercury Investments, L.P., which holds 979,050 A Common Shares and 172,939 Class B Common Shares ("B Common Shares"). The sole member of Mercury Assets Delaware LLC is Benjerome Trust. Mr. Fox is the sole trustee of the Benjerome Trust. Mr. Fox disclaims beneficial ownership of these securities except to the extent of his indirect pecuniary interest therein.

Common Shares owned indirectly by Fox Paine Global, Inc. through its indirect limited partnership interest in Fox Mercury Investments, L.P., which holds 979,050 A Common Shares and 172,939 B Common Shares. Mr. Fox is a director of Fox Paine Global, Inc. Mr. Fox disclaims beneficial ownership of these securities except to the extent of his indirect pecuniary interest therein.

Common Shares held by Mercury Assets Delaware LLC, which holds 550,000 Class A-2 Common Shares. The sole member of Mercury Assets Delaware LLC is Benjerome Trust. Mr. Fox is the sole trustee of the Benjerome Trust. Mr. Fox disclaims beneficial ownership of these securities except to the extent of his indirect pecuniary interest therein.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025.


Effective at the close of business on August 7, 2025, the reporting person no longer serves as Co-Chief Executive Officer and Co-President of Goldman Sachs Middle Market Lending Corp. II.


/s/ Brian Poff, Attorney-In-Fact for Esteban Lopez


A substantial number of such shares are unvested performance shares and restricted stock units subject to a risk of forfeiture under certain circumstances.


Shares were acquired pursuant to a dividend reinvestment program offered through a personal brokerage account.

Represents dividend equivalent rights (DER), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and the related DERs vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Certain underlying awards are fully vested and are subject to a deferred delivery feature, these same terms apply to the related DERs.

/s/ Priscilla Duncan-Tannous, Attorney-in-Fact


The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $14.095 to $14.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Mr. Smith also serves as the Senior Vice President, General Counsel and Corporate Secretary of CTO Realty Growth, Inc. ("CTO"). Mr. Smith disclaims beneficial ownership of all equity securities of the Issuer that are or may be beneficially owned by CTO or any of its affiliates. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that Mr. Smith is, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities of the Issuer that are or may be beneficially owned by CTO or any of its affiliates.


The amount of securities owned following the reported transaction reflects direct ownership of all shares of common stock, including restricted shares.

By Lee N. Davis under Power of Attorney dated as of December 5, 2024


These securities are held by accounts managed by GoldenTree Asset Management LP. GoldenTree Asset Management LLC (the "General Partner") is the general partner of GoldenTree Asset Management LP. Steven A. Tananbaum is the managing member of the General Partner. Accordingly, each of the foregoing entities and Steven A. Tananbaum may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein, if any.

The securities are held of record by GoldenVest LLC. Steven A. Tananbaum is the managing member of GoldenVest LLC and therefore may be deemed to share beneficial ownership of the securities held of record by GoldenVest LLC. Steven A. Tananbaum disclaims any such beneficial ownership except to the extent of his pecuniary interest therein, if any.


Ordinary Shares

Ordinary Shares

Performance share unit (PSU) award granted on August 15, 2024 (for Mr. Keane's role as Chief Executive Officer of Cimpress plc) with performance conditions based on revenue, adjusted EBITDA, and unlevered free cash flow of Cimpress plc for the fiscal year ended June 30, 2025. On August 7, 2025, Cimpress' Compensation Committee determined the number of shares issuable pursuant to this PSU award based on the level of achievement against the performance conditions, with each PSU representing Cimpress' commitment to issue one ordinary share.

These PSUs vest over the following four-year period: 25% of the number of shares determined to be issuable vest on the Date Exercisable shown in Table II and 6.25% of such number of shares vest quarterly thereafter.

Performance share unit (PSU) award granted on August 15, 2024 (for Mr. Keane's role as a member of the Board of Directors of Cimpress plc) with performance conditions based on revenue, adjusted EBITDA, and unlevered free cash flow of Cimpress plc for the fiscal year ended June 30, 2025. On August 7, 2025, Cimpress' Compensation Committee determined the number of shares issuable pursuant to this PSU award based on the level of achievement against the performance conditions, with each PSU representing Cimpress' commitment to issue one ordinary share.

/s/ Matthew F. Walsh, as attorney-in-fact for Robert S. Keane


MacKenzie Realty Capital Inc. Common Stock

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.18 to $4.50, inclusive. The reporting person undertakes to provide to MacKenzie Realty Capital, Inc. (MKZR), any security holder of MKZR, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 1 to this Form 4.

MacKenzie Real Estate Advisers, LP ("MREA") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MREA and therefore could be deemed to beneficially own the MRC shares acquired by MREA, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.51 to $4.76, inclusive. The reporting person undertakes to provide to MacKenzie Realty Capital, Inc. (MKZR), any security holder of MKZR, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased  at each separate price within the ranges set forth in footnote 3 to this Form 4.

The filer is now disclosing the total amount owned by MPF Successors rather than his pecuniary interest in such shares, and disclaiming the amount in excess of his pecuniary interest. All share amounts indicated above are after the 1 for 10 reverse stock split effective August 4, 2025.

MPF Successors, LP ("MPF") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MPF and therefore could be deemed to beneficially own the MRC shares acquired by MPF, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

/s/ Jeri Bluth, as attorney-in-fact for Robert Dixon


Baumgartner Florian

C/O CIMPRESS PLC, FIRST FLOOR BUILDING 3

Ordinary Shares

Performance share unit (PSU) award granted on August 15, 2024 with performance conditions based on revenue, adjusted EBITDA, and unlevered free cash flow of Cimpress plc's Vista business for the fiscal year ended June 30, 2025. On August 7, 2025, Cimpress' Compensation Committee determined the number of shares issuable pursuant to this PSU award based on the level of achievement against the performance conditions, with each PSU representing Cimpress' commitment to issue one ordinary share.

/s/ Matthew F. Walsh, as attorney-in-fact for Florian Baumgartner


Ordinary Shares

Performance share unit (PSU) award granted on August 15, 2024 with performance conditions based on revenue, adjusted EBITDA, and unlevered free cash flow of Cimpress plc for the fiscal year ended June 30, 2025. On August 7, 2025, Cimpress' Compensation Committee determined the number of shares issuable pursuant to this PSU award based on the level of achievement against the performance conditions, with each PSU representing Cimpress' commitment to issue one ordinary share.

/s/ Matthew F. Walsh, as attorney-in-fact for Maarten Wensveen


Effective at the close of business on August 7, 2025, the reporting person no longer serves as Co-Chief Executive Officer and Co-President of Goldman Sachs Private Middle Market Credit II LLC.


Class A Common Stock

Each share of the Class A Common Stock was issued upon conversion of one share of Class B Common Stock at the election of the Reporting Person.

These shares are held directly by The Freedom Revocable Trust dated February 28, 2017 as amended, and for which the Reporting Person serves as trustee.

A portion of these securities are Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the election of the Reporting Person and has no expiration date.

/s/ Mark Reinstra Attorney-in-Fact for David Baszucki


The Reporting Person was awarded 12,597 shares of restricted stock, which vest in equal monthly installments on the end of each month beginning on August 31, 2025 through December 31, 2025, contingent upon continued service as a member of the board of directors of Great Elm Group, Inc. ("GEG").


Ordinary Shares

/s/ Matthew F. Walsh, as attorney-in-fact for Sean E. Quinn


The Reporting Person and spouse as Co-Trustees of a trust for the benefit of the Reporting Person.

/s/ Jennifer Ferrero (as attorney-in-fact for William K. Daniel)


Common Stock

Common Stock

Common Stock

Each of the reported securities represent awards made pursuant to the Company's 2024 Omnibus Equity Incentive Plan in connection with the Company's 2025 Long-Term Incentive Program.

Each restricted stock unit represents a contingent right to receive one share of KORU Medical Systems, Inc. (the "Company") upon vesting.

One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier change in control of the Company.

These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027 or upon an earlier change in control of the Company. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027.

One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof.

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.


Common Stock

Common Stock

Common Stock

One-fourth will vest on May 12, 2026 and on each first, second and third anniversary thereof or upon an earlier chance in control of the Company.


Effective at the close of business on August 7, 2025, the reporting person no longer serves as Co-Chief Executive Officer and Co-President of Goldman Sachs Private Credit Corp.


Represents shares withheld by the Issuer in accordance with the terms of the award to satisfy tax withholding obligations in connection with the payout of vested restricted stock units previously granted to the reporting person (such restricted stock units previously reported in Table I of Form 4). Also represents an adjustment of .6189 shares to adjust for fractional shares that were disregarded upon vesting of the restricted stock unit award.

By: /s/ Rebecca Cottrell For: Kate Duchene


Represents shares withheld by the Issuer in accordance with the terms of the award to satisfy tax withholding obligations in connection with the payout of vested restricted stock units previously granted to the reporting person (such restricted stock units previously reported in Table I of Form 4). Also represents an adjustment of .4237 shares to adjust for fractional shares that were disregarded upon vesting of the restricted stock unit award.

By: /s/ Rebecca Cottrell For: Bhadreskumar Patel


Withholding of shares to pay the tax liability associated with vesting of restricted shares.


Represents shares withheld by the Issuer in accordance with the terms of the award to satisfy tax withholding obligations in connection with the payout of vested restricted stock units previously granted to the reporting person (such restricted stock units previously reported in Table I of Form 4). Also represents an adjustment of .2268 shares to adjust for fractional shares that were disregarded upon vesting of the restricted stock unit award.

By: /s/ Rebecca Cottrell For: Jennifer Ryu


Reflects the weighted average sale price. The shares were sold in multiple transactions at prices ranging from a low of $163.97 to a high of $164.9550 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth with respect to this transaction and all sale transactions reported in this Form 4 as described in footnotes 3-5.

Includes 398 shares of Common Stock acquired under the ITT  Inc. 2023 Employee Stock Purchase Plan.

Reflects the weighted average sale price. The shares were sold in multiple transactions at prices ranging from a low of $164.97 to a high of $165.6950 per share, inclusive.

Reflects the weighted average sale price. The shares were sold in multiple transactions at prices ranging from a low of $165.09 to a high of $166.05 per share, inclusive

Reflects the weighted average sale price. The shares were sold in multiple transactions at prices ranging from a low of $166.18 to a high of $166.8150 per share, inclusive.

The sales are being made to facilitate the Reporting Person's purchase of a new personal residence near ITT Inc.'s headquarters. Prior to executing the reported transactions, the Reporting Person terminated a previously disclosed Rule 10b5-1 trading arrangement that he had adopted for the same purpose.

/s/ Tymour Okasha, Assistant Secretary for ITT Inc.; by Power of Attorney for Luca Savi


Common Stock

Common Stock

Common Stock

These restricted stock units will vest based upon achievement of certain performance conditions as of December 31, 2027. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved, multiplied by between 0.5 to 1.5 times of the earned number of shares. These restricted stock units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2027.

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.


Mark J. Weikel by: /s/ Robert C. Lambourne, as Attorney-in-fact


Common Stock

Represents shares of restricted stock issued as an employment inducement award that vest 25% annually commencing July 28, 2026, subject to acceleration as provided in his employment agreement.

One-fourth will vest on August 1, 2026 and on each first, second and third anniversary thereof.


The transaction was executed in multiple trades at prices ranging from $159.51 to 159.65, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in footnote 1 of this Form 4.


Represents restricted shares granted for prospective service from July 24, 2025 to the 2026 Annual Meeting of Shareholders which are scheduled to vest on August 7, 2026.

Direct total includes restricted shares of Equity Residential scheduled to vest in the future.


Accrual of dividend equivalents on deferred stock units.

/s/ Katherine M. Serevitch, Attorney-in-Fact


Effective at the close of business on August 7, 2025, the reporting person no longer serves as Co-Chief Executive Officer and Co-President of Goldman Sachs BDC, Inc.


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $53.26 to $53.56, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.


Represents the weighted average per share price of sales transacted on August 8, 2025; such sales were conducted through various transactions at per share sale prices ranging from $105.510 to
$106.225, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information
regarding the number of shares sold at each separate price within the aforementioned range.

Represents shares previously acquired in transactions exempt under Rule 16b-3(c).


Common Stock, par value $0.001 per share ("Common Stock")

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at a price of $5.50 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price.

Represents securities owned directly by Mink Brook Partners LP (the "Fund"). As the investment manager of the Fund, Mink Brook Asset Management LLC may be deemed to beneficially own the securities owned directly by the Fund.

Mink Brook Asset Management LLC, and the general partner for both funds, Mink Brook Capital GP LLC, disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Mink Brook Asset Management LLC, Mink Brook Capital GP LLC or William Mueller as managing member of both, is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Represents securities owned directly by Mink Brook Opportunity Fund LP (the "Fund"). As the investment manager of the Fund, Mink Brook Asset Management LLC may be deemed to beneficially own the securities owned directly by the Fund.


The transaction reported in this Form 4 reflects withholding of shares of common stock to satisfy tax withholding obligations resulting from the vesting of restricted stock.

Some of these shares are restricted shares that are subject to time-vesting restrictions.


Represents the disposition of shares to the company to cover taxes on the vesting of awards.

/s/ Dara Steele-Belkin, attorney-in-fact for Robert M. Cortopassi


The common stock is being granted as restricted stock units, 100% of which shall vest on the later of the one-year anniversary of the date of grant, or the date of the 2026 Annual Meeting of Shareholders.

The sale reported in this Form 4 was effected pursuant to an existing Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

/s/ Danielle Abrahamsen, Attorney-in-Fact


Tax withholding upon vesting of restricted stock units.

Reflects a correction to the number of shares reported as acquired through dividend reinvestment in certain prior periods, which due to an administrative error had been overstated by 2,379.91 shares in the aggregate, and includes 3,462.22 shares acquired through dividend reinvestment since the reporting person's last report.


Common Stock

Common Stock

Common Stock

Common Stock

Includes 284 aggregate shares of the Company's common stock acquired under the Frontdoor, Inc. 2019 Employee Stock Purchase Plan on June 30, 2025.

This transaction was executed in multiple trades at prices ranging from $55.94 to 57.04, inclusive.  The price reported above reflects the weighted average sales price.  The reporting person hereby undertakes to provide the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Non-qualified stock options granted on March 29, 2019 vested 25% on March 29, 2020, and thereafter vested 6.25% quarterly over the next three years on the quarterly anniversary of the grant date, such that all shares vested on March 29, 2023, subject to continued employment with the Company.

Non-qualified stock options granted on March 30, 2020 vested 25% on March 30, 2021, and thereafter vested 6.25% quarterly over the next three years on the quarterly anniversary of the grant date, such that all shares vested on March 30, 2024, subject to continued employment with the Company.

Reflects non-qualified stock options with time- and performance-based vesting conditions awarded to the Reporting Person on June 1, 2022.  The performance criteria vested in three performance tranches, each with a separate performance condition based on the volume-weighted average price of the Company's common stock on the NASDAQ of $35.00, $40.00 and $45.00, respectively, over any 20 consecutive trading-day period.  The service condition was satisfied on June 1, 2023.  The performance-vesting criteria was met on August 18, 2023, August 9, 2024 and September 23, 2024 for the first, second and third tranches of the award, respectively, as certified by the Compensation Committee of the Company's Board of Directors.

Reflects non-qualified stock options with time- and performance-based vesting conditions awarded to the Reporting Person on March 27, 2023.  The performance criteria vested in three performance tranches, each with a separate performance condition based on the volume-weighted average price of the Company's common stock on the NASDAQ of $32.23, $35.14 and $38.31, respectively, over any 20 consecutive trading-day period.  The service condition was satisfied on March 27, 2024.  The performance-vesting criteria was met on July 20, 2023, August 8, 2023 and August 2, 2024 for the first, second and third tranches of the award, respectively, as certified by the Compensation Committee of the Company's Board of Directors.

Stephanie Delavale, as Attorney-In-Fact for Jeffrey Fiarman


Accrual of dividend equivalents on deferred stock units.


/s/ Ashley Dagley, Attorney-in-fact for James Douglas Allen


The purchase price represents the weighted average price of shares purchased ranging from $48.49 to $48.62 per share, and is rounded to the nearest tenth of a cent. Upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

/s/ Karole Morgan-Prager, Attorney-in-Fact


Shares were sold in multiple transactions, each transaction at $88.44. The reporting person undertakes to provide, upon request by Jackson Financial Inc., any security holder of Jackson Financial Inc., or the staff of the U.S. Securities and Exchange Commission, full information regarding the number of shares sold at the price set forth in this footnote.

Shares were sold in multiple transactions, each transaction at $89.96. The reporting person undertakes to provide, upon request by Jackson Financial Inc., any security holder of Jackson Financial Inc., or the staff of the U.S. Securities and Exchange Commission, full information regarding the number of shares sold at the price set forth in this footnote.

Shares were sold by the Craig D Smith TTEE Craig D Smith TR dated May 8, 2023, U/A 5/8/03 FBO Craig D. Smith, where reporting person is the trustee and beneficiary.


The sale reported in this Form 4 was effected pursuant to an existing Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2025.


The transaction was executed in multiple trades at prices ranging from $867.15 to $867.825. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $869.56 to $870.13. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $870.61 to $871.585. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $871.6579 to $872.34. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ Joshua Isner, by Isaiah Fields, Attorney-in-Fact


Accrual of dividend equivalents on deferred shares.


The common stock is being granted as restricted stock units, 100% of which shall vest on the later of the one-year anniversary of the date of grant, or the date of the 2026 Annual Meeting of Shareholders.


Donna Kalazdy, by power of attorney for Gregory Hayes


Ordinary Shares

Ordinary Shares

These stock options become exercisable as follows: 33% on the first and second anniversary of the date of the grant and the remaining 34% on the third anniversary of the date of the grant.

Executive Vice President and Chief Financial Officer of Eaton Corporation, a subsidiary of the Issuer. Power of Attorney is attached hereto as Exhibit 24.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Represents shares of common stock of the Issuer received on December 21, 2023, as consideration pursuant to that certain Merger Agreement, dated as of June 27, 2023 (as amended on September 22, 2023 and as may be further amended and/or restated from time to time, the "Merger Agreement"), by and among Airship AI Holdings, Inc., a Delaware corporation (the "Issuer") (formerly known as BYTE Acquisition Corp., a Cayman Island exempted company limited by shares, prior to its domestication as a Delaware corporation), BYTE Merger Sub, Inc., a Washington corporation and a direct, wholly-owned subsidiary of the Issuer, and Airship AI, Inc., a Washington company (formerly known as Airship AI Holdings, Inc., "Airship AI"). The Reporting Person received the reported shares in exchange for shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Airship Kirkland Family Limited Partnership is the record holder of the securities reported herein. Victor Huang is the managing partner of Airship Kirkland Family Limited Partnership and as such has voting and dispositive power over these securities. Mr. Huang disclaims beneficial ownership of the securities held by Airship Kirkland Family Limited Partnership, except to the extent of his pecuniary interest therein.

Represents options to purchase shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of options to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents stock appreciation rights denominated in shares of common stock of the Issuer received on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of stock appreciation rights denominated in shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Represents warrants to purchase shares of common stock of the Issuer received by the Reporting Person on December 21, 2023, pursuant to the Merger Agreement, upon the conversion of warrants to purchase shares of common stock of Airship AI at the Conversion Ratio, as defined in the Merger Agreement, as of the Effective Time of the Merger.

Pursuant to earnout provisions in the Merger Agreement, the holder of such Earnout Rights is entitled to receive shares of common stock of the Issuer upon the occurrence of certain operating performance and share price performance milestones during the applicable earnout periods set forth in the Merger Agreement.

Options vest quarterly over 4 years.

The Reporting Person files this Amendment No. 1 to its original Form 4 dated 01/07/2025 to correctly reflect the transaction and ending balance.


On June 27, 2024, the reporting person was granted restricted stock units ("RSUs") to acquire a total of 100,375 shares of common stock that vested based on the achievement of certain performance-based milestones and subject to continuous service. On August 7, 2025, the milestones were deemed to be achieved, resulting in the vesting of the RSUs as to all 100,375 shares.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025.

This transaction was executed in multiple trades at prices ranging from $41.26  to $42.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

/s/ Shanti Ariker pursuant to power of attorney


These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.25 to $40.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Pursuant to an agreement between the Reporting Person and his former spouse, the Reporting Person has sole voting control over the shares. The Reporting Person has no pecuniary interest in the shares.


The transaction was executed in multiple trades at prices ranging from $870.33 to $871.04. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $871.335 to $872.33. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ Caitlin E. Kalinowski by Isaiah Fields, Attorney-in-Fact


Represents the weighted average purchase price per share. The shares were purchased in the open market in multiple transactions at prices ranging from $11.13 to $11.16 per share. The Reporting Person undertakes that he will provide full information regarding the number of shares purchased at each price upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

/s/ Rebecca Schuster by power of attorney


Common Stock

The entire option award shall vest on the earlier of:  (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.

/s/ Dov A. Goldstein as attorney-in-fact


These holdings reflect the Reporting Person's units in the Seneca Foods Corporation Stock Fund (the "Stock Fund") under the 401(k) Plan. The Stock Fund is a unitized stock fund that holds shares of Class A common stock as well as shares of Class B common stock. A cash balance is also maintained in the Stock Fund to facilitate transfers between investment fund options in the 401(k) Plan. The actual number of shares of Class A common stock and Class B common stock owned by the Reporting Person fluctuates daily based on the Stock Fund's aggregate holdings. The Reporting Person's holdings under the 401(k) Plan also include additional units acquired in connection with elective deferrals and Company matching contributions since the Reporting Person's last beneficial ownership report. Those transactions were exempt from reporting pursuant to Rule 16a-3(f)(1)(i)(B).

Award of restricted stock pursuant to the Company's 2007 Equity Incentive Plan, which was originally approved by the shareholders of the Company on August 10, 2007 and amended and extended July 2017. No price was paid by the Reporting
Person in connection with this award of shares of restricted stock which vests 25% per year over the next four years.


Award of restricted stock pursuant to the Company's 2007 Equity Incentive Plan, which was originally approved by the shareholders of the Company on August 10, 2007 and amended and extended July 2017. No price was paid by the reporting person in connection with this award of shares of restricted stock which vests 25% per year over the next four years.


Grant of restricted stock units vesting in three annual installments of 33%, 33% and 34% on August 8, 2026, August 8, 2027 and August 8, 2028, respectively.


/s/ Victor L. Cangelosi, pursuant to Power of Attorney


Represents the weighted average purchase price per share. The shares were purchased in the open market in multiple transactions at prices ranging from $10.89 to $10.96 per share. The Reporting Person undertakes that she will provide full information regarding the number of shares purchased at each price upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.


Mr. Corbett serves as trustee of Corbett Living Trust, and holds all shares indirectly through the trust.


Shares acquired in exchange for the repayment of indebtedness.


Award of restricted stock pursuant to the Company's 2007 Equity Incentive Plan, which was originally approved by the shareholders of the Company on August 10, 2007 and amended and extended July 2017.  No price was paid by the reporting person in connection with this award of shares of restricted stock which vests 25% per year over the next four years.


Table I price constitutes an average sales price over multiple tranches.


The price reported in Column 4 for all transactions on this report is a weighted average price. The shares sold in footnotes (1) through (2) were sold in multiple transactions at the price ranges provided in footnotes (1) through (2). These shares in footnote (1) were sold in multiple transactions at prices ranging from $321.2300 to $321.6700 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1) through (2) upon request by the SEC staff, the issuer or any shareholder of the issuer.

These shares were sold in multiple transactions at prices ranging from $322.8200 to $323.2650 inclusive.


Frank D. and Donna M. Martell Family Trust

This transaction was executed in multiple trades at prices ranging from $1.19 to $1.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.


Represents the weighted average purchase price per share. The shares were purchased in the open market in multiple transactions at prices ranging from $10.94 to $10.95 per share. The Reporting Person undertakes that he will provide full information regarding the number of shares purchased at each price upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.


/s/ David Gordon, as attorney-in-fact for Jonathan S. Morgan


Represents the weighted average purchase price per share. The shares were purchased in the open market in multiple transactions at prices ranging from $10.94 to $11.275 per share. The Reporting Person undertakes that he will provide full information regarding the number of shares purchased at each price upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.2150 to $14.2201, inclusive.

Includes 28,606 restricted stock units ("RSUs") granted on December 27, 2024 to non-employee directors for board service. The RSUs represent a contingent right to receive shares of common stock of Applied Digital Corporation (the "Issuer") on a one-for-one basis, have no expiration date, and vest in full on November 20, 2025, subject to the Reporting Person's continued service through such date.

Includes 200,000 shares of restricted stock granted to the Reporting Person on May 13, 2024 in connection with the Reporting Person's service as the Chairman of the board of directors of Applied Digital Cloud Corporation, a subsidiary of the Issuer. The shares of restricted stock vest as follows: 100,000 shares on May 13, 2026 (the second anniversary of the grant date) and 100,000 shares on May 13, 2027 (the third anniversary of the grant date), provided that the Reporting Person is a director of both the Issuer and Applied Digital Cloud Corporation on each such date.


The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan that was adopted on March 7, 2025.

Certain of these securities are represented by restricted stock units.

/s/ Kimberly Hackman, by power of attorney


Class A Common Stock

Class A Common Stock

Shares of Class B Common Stock were converted at a 1:1 ratio for a share of Class A Common Stock at the election of the Reporting Person.

The shares are held by The AF Living Trust UTA dated 9/4/19 for which the Reporting Person serves as the trustee.

The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan that was adopted on March 6, 2025.

This sale price represents the weighted average sale price of the shares sold ranging from $275.00 to $275.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

This sale price represents the weighted average sale price of the shares sold ranging from $276.01 to $276.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

This sale price represents the weighted average sale price of the shares sold ranging from $277.11 to $277.65 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.


Common Stock

The Reporting Person was granted an option to purchase up to 25,000 shares of the Corporation's common stock pursuant to the 2019 Equity Incentive Plan. These 25,000 shares vest as follows: (i) 8,750 shares are immediately exercisable, and (ii) the remaining 16,250 shares vest ratably in monthly installments commencing August 31, 2025 and ending on February 28, 2028, provided that the Reporting Person remains as a consultant or employee of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions.


At his request and with the approval of the Agenus Inc. Compensation Committee,  Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending August 8, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.

$4.80 is the closing price of our Common Stock on August 8, 2025, the last trading day for the payroll date for the pay period ending August 8, 2025.

Shares are held in Dr. Armen's IRA accounts.

Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

/s/Christine M. Klaskin, as Attorney-in-Fact for Garo H. Armen


These securities were sold by TBS Legacy Investments, Ltd. in which the Stice 2023 Children's Trust holds 100% of the limited partnership units. Mr. Stice's adult children are the beneficiaries of the Stice 2023 Children's Trust.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $140.91 per share to $141.89 per share, inclusive. The reporting person undertakes to provide to Diamondback Energy, Inc., any security holder of Diamondback Energy, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnotes 4 through 9.

The Stice 2023 Children's Trust for the benefit of Mr. Stice's adult children is the limited partner of TBS Legacy Investments, Ltd. Mr. Stice and his spouse serve as the trustees of the Stice 2023 Children's Trust and, as a result, may be deemed to have beneficial ownership of the securities in which their adult children have a pecuniary interest. Further, Stice Management, LLC serves as the general partner of TBS Legacy Investments, Ltd. Mr. Stice and his spouse hold 100% of the membership interests in Stice Management, LLC, of which Mr. Stice is the manager.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $141.92 per share to $142.91 per share, inclusive.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $143.00 per share to $143.92 per share, inclusive.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $144.025 per share to $145.00 per share, inclusive.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $145.08 per share to $146.025 per share, inclusive.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $146.165 per share to $147.08 per share, inclusive.

The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $147.36 per share to $147.51 per share, inclusive.

These securities are held by Stice Investments, Ltd., which is managed by Stice Management, LLC, its general partner. Mr. Stice and his spouse hold 100% of the membership interests in Stice Management, LLC, of which Mr. Stice is the manager.

/s/ Teresa L. Dick, as attorney-in-fact for Travis D. Stice


/s/ Rajbir S. Denhoy, Chief Financial Officer, by power of attorney


Class B Common Stock

Class A Common Stock

Class A Common Stock

Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 26, 2025.

The stock option vested in 36 equal monthly installments after September 2, 2020, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date.  The stock option was granted on September 2, 2020.

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

/s/ Jennifer Chaloemtiarana, Attorney-in-Fact


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.09 to $12.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

/s/ Crystal L. Gordon, Attorney-in-Fact for Christopher John Moore


Class A Common Stock

8,245,000 shares of Class A Common Stock were issued to the Reporting Person in exchange for an equal number of Paired Interests (as defined below) that were surrendered by the Reporting Person pursuant to the Amended and Restated Exchange Agreement, dated as of December 2, 2021 and amended and restated as of March 23, 2022 (the "Exchange Agreement"), among the Issuer, The Hagerty Group, LLC ("OpCo"), the Reporting Person, Markel Corporation ("Markel") and each of the Reporting Person's and Markel's Qualified Transferees (as defined therein). Each "Paired Interest" consists of one share of Class V Common Stock of the Issuer and one unit of limited liability company interest of OpCo and may be surrendered by the Reporting Person pursuant to the Exchange Agreement in exchange for a share of Class A Common Stock of the Issuer or, at the option of the Issuer, cash.

Each Paired Interest has no expiration date and may be surrendered by the Reporting Person pursuant to the Exchange Agreement in exchange for a share of Class A Common Stock of the Issuer or, at the option of the Issuer, cash.

HAGERTY HOLDING CORP. By: /s/ Jessica Sullivan Name: Jessica Sullivan Title: Secretary


These shares represent a quarterly payment of the reporting person's annual retainer under the Allison Transmission Holdings, Inc. (the "Company") Eighth Amended and Restated Non-Employee Director Compensation Policy. The annual retainer is paid quarterly in arrears in cash or common stock at the reporting person's discretion.

The number of shares of common stock received was calculated based on $87.41, which was the closing price of the Company's common stock on the date of grant.


Class A Common Stock

On January 27, 2025, the issuer effected a 25 to 1 reverse stock split of its Class A Common Stock. The number of shares of Class A Common Stock reported on this Form 4 has been adjusted to reflect the reverse stock split.

This Form 4 is being filed late due to inadvertent administrative error.


Bhairav Patel, Attorney infact for Anne Olson


Bhairav Patel, Attorney in Fact for John Schissel


Common Stock

This stock appreciation right fully vested on 07/20/2023. All shares have been exercised.


Common stock

Common stock

This total includes 971 units of Modine common stock held in the Reporting Person's Modine 401(k) Retirement Plan account.


CoTrustee of P. M. Bristow 2019 Irr Family Trust

By Southern BancShares (N.C.), Inc and subsidiary

The reporting person is a director, officer, manager and/or shareholder of the companies that own these shares, but she disclaims beneficial ownership of the listed shares except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.

Each Depositary Share represents a 1/40th interest in a share of the Issuer's 5.375% Non-Cumulative Perpetual Preferred Stock, Series A.

Olivia B. Holding, By: E. Knox Proctor V , Attorney-in-fact


COMMON STOCK

This amount includes 1,128 shares of time-based restricted common stock solely owned by Mr. Bone: 8,384 shares held jointly with his spouse; 890 shares co-owned with Mr. Bone's father and siblings; and 77.0994 shares owned solely by Mr. Bone which includes 0.960 shares acquired 6/13/2025 under the Issuer's Dividend Reinvestment and Stock Purchase Plan.

Each restricted stock unit represents a contingent right to receive one share of PFIS common stock.

The restricted stock units vest in three equal annual installments beginning March 11, 2026.

/s/ Stephanie A. Westington, CPA as Attorney in Fact for James Bone, Jr., CPA


Common Stock


By Southern BancShares (N.C.), Inc. and subsidiary

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.

Hope H. Bryant, By: E. Knox Proctor V, Attorney-in-fact


Common Stock

This stock appreciation right fully vested on 12/29/2021. All shares have been exercised.


Common Stock

Common Stock

Common Stock

Common Stock


Thirdline Real Estate Income Fund Common Shares


Held In Trust Under Issuer's Retirement Plan

/s/ Stanley Scott Luton, attorney-in-fact


/s/ Robert Stieger, by POA from Reporting Person


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.61 - $27.33. The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.

The total reported in Column 5 of this Form 4 includes 39 shares of common stock, acquired by the reporting person under the Company's employee stock purchase program, in Q1 of 2025, and 17.24 shares of common stock, acquired by the reporting person under the Company's dividend reimbursement plan, in Q2 of 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.59 - $27.35. The reporting person undertakes to provide to AMAL, any security holder of AMAL, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.


Held in Trust Under Issuer's Retirement Plan


Includes shares acquired pursuant to dividend reinvestment in transactions exempt from Section 16 pursuant to Rule 16a-11.


Common Stock

Common Stock

Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of UEI common stock.

These shares are held in the Hackworth Living Trust. Mr. Hackworth disclaims beneficial ownership of the shares.

This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4.

The restricted stock units vest in accordance with the vesting schedule of each RSU grant.

This figure represents an aggregate number of restricted stock units held by Reporting Person.

Each performance stock unit represents a contingent right to receive one share of UEI common stock.

The performance stock units vest in accordance with the vesting schedule of each PSU grant.

This figure represents an aggregate number of performance stock units held by Reporting Person.

Exercise Price determined in accordance with the terms of the Company's applicable Stock Incentive Plan.

The Exercisable and Expiration Dates were reported at the time the Stock Options were granted.

This figure represents an aggregate number of stock options held by Reporting Person.

/s/Bryan M. Hackworth, by Bryan Allison, pursuant to Limited Power of Attorney dated May 8, 2024


EXPEDITORS INTERNATIONAL OF WASHINGTON INC

Balance of Common Stock beneficially owned includes 172.3903 shares purchased on July 31, 2025 under Expeditors International of Washington, Inc.'s 2002 Employee Stock Purchase Plan.

Diane Heffner, Stock Plan Administrator, attorney-in-fact


This transaction was made pursuant to a written plan that became effective 5/1/25.

/s/ Melinda Kilburn for Katherine W Shattuck, 03.20.25, Attorney-in-Fact


/s/ Melinda S Kilburn for Frank Pellegrino, 3/20/25, Attorney-in-Fact


CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND


Common Stock

Common Stock

Common Stock

Common Stock

The restricted stock units vest in accordance with the vesting schedule of each RSU Grant.

The performance stock units vest in accordance with the vesting schedule of each PSU Grant.

Exercise Price Determined in accordance with the terms of the Company's applicable Stock Incentive Plan.

/s/Richard K. Carnifax, by Bryan Allison, pursuant to Limited Power of Attorney dated May 7, 2024


Purchase pursuant to the 2021 Employee Stock Purchase Plan.

Includes holdings in Union Pacific's Payroll-based and Tax-reduction stock ownership plans and 401(k) plan.

By: Trevor L. Kingston, Attorney-in-Fact For: Kenyatta G. Rocker


By: Trevor L. Kingston, Attorney-in-Fact For: Carrie J. Powers


By: Trevor L. Kingston, Attorney-in-Fact For: Rahul Jalali


By: Trevor L. Kingston, Attorney-in-Fact For: Jennifer L. Hamann


By: Trevor L. Kingston, Attorney-in-Fact For: Christina B. Conlin


Common Stock

Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of UEI common stock.

This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4.

These shares are held in a tax deferred annuity company of which Mr. Chong owns 100% and as to which Mr. Chong disclaims beneficial ownership.

The restricted stock units vest in accordance with the vesting schedule of each RSU grant.

This figure represents an aggregate number of restricted stock units held by Reporting Person.

Each performance stock unit represents a contingent right to receive one share of UEI common stock.

The performance stock units vest in accordance with the vesting schedule of each PSU grant.

This figure represents an aggregate number of performance stock units held by Reporting Person.

Exercise Price determined in accordance with the terms of the Company's applicable Stock Incentive Plan.

The Exercisable and Expiration Dates were reported at the time the Stock Options were granted.

This figure represents an aggregate number of stock options held by Reporting Person.

/s/David Cheung Hyen Chong, by Bryan Allison, pursuant to Limited Power of Attorney dated May 7, 2024


Held In Trust Under Issuer's Retirement Plan By Spouse


Common Stock

Common Stock

Common Stock

Common Stock

/s/Ramzi Ammari, by Bryan Allison, pursuant to Limited Power of Attorney dated May 7, 2024


This transaction was executed in multiple trades at prices ranging from $82.16 to $81.96 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.


Includes shares acquired through a dividend reinvestment plan since the reporting person's last Form 4 filing.


These represent deferred stock units ("DSU") that were awarded as part of the Company's compensation program for non-management directors in connection with the 2025 annual stockholders' meeting. Each DSU constitutes the right to receive one share of the Company's common stock upon settlement (which occurs when the recipient's service with the Company is concluded). During the remaining term of service, DSUs are nontransferable and carry neither voting nor dividend rights. DSUs are subject to the terms and conditions of the Company's standard form DSU agreement.


/s/ James Bramble, attorney-in-fact for Randall D. Miles


Phantom Stock Acquired Under the Deferred Compensation Plan

Common Shares

The amount reported includes additional common shares acquired pursuant to the dividend reinvestment feature of the IRA as reported in the plan statement dated June 30, 2025.

The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan for Directors, as amended (the "Plan") track WOR common shares on a one-for-one basis.

Prior to October 1, 2014, the account balances related to the phantom stock investment option could be immediately transferred to other deemed investment options under the terms of the Plan. The Plan provides that, effective October 1, 2014 and thereafter, any amount credited in a participant's account to the phantom stock fund may not be transferred to an alternative deemed investment option under the Plan until distribution from the Plan.  Distributions are made only in WOR common shares and generally commence upon leaving Worthington Enterprises, Inc. and its subsidiaries.

The amount reported includes the additional unfunded theoretical common shares (i.e., phantom stock) credited pursuant to the dividend reinvestment feature of the 2005 NQ Plan on June 30, 2025.

/s/Patrick J. Kennedy, as attorney-in-fact for Joseph B. Hayek


Common Shares

The information in this report is based on a 401(k) Plan statement dated as of August 8, 2025.

The theoretical WOR common shares ("phantom stock") credited to the reporting person's account in the Worthington Industries, Inc. Amended and Restated 2005 Deferred Compensation Plan, as amended (the "Plan") track WOR common shares on a one-for-one basis.

The amount reported includes the additional unfunded theoretical common shares (i.e., phantom stock) credited pursuant to the theoretical Worthington Enterprises, Inc. common shares deemed investment option pursuant to the dividend reinvestment feature of the 2005 NQ Plan on June 30, 2025.

/s/Patrick J. Kennedy, as attorney-in-fact for Kevin J. Chan


By Spouse as Trustee for the Ruth P. Holding 2025 GRAT

As custodian for James Freeman Bailey, Jr.

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose.

Frank B. Holding, Jr., By: E. Knox Proctor V, Attorney-in-fact


/s/ Steven C. Babinski, Attorney-in-Fact


Common Shares

The options vest as follows: 1/3 on 8/11/2026; 1/3 on 8/11/2027; and 1/3 on 8/11/2028.

/s/ Tricia Pannier as attorney-in-fact for Ali Erfan


This transaction was executed in multiple trades at prices ranging from $34.00 to $35.00 per share. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

/s/ Rajbir S. Denhoy, Chief Financial Officer, by power of attorney


Represents restricted stock units ("RSUs") granted on March 24, 2025. The RSUs will vest in 3 equal annual installments beginning March 24, 2026, and convert to shares of common stock of the Issuer on a 1-for-1 basis upon vesting, subject to the reporting person's continuous employment until the applicable vesting date.

Represents restricted stock units ("RSUs") granted on March 24, 2025. The RSUs will vest in 2 equal annual installments beginning March 24, 2026, and convert to shares of common stock of the Issuer on a 1-for-1 basis upon vesting, subject to the reporting person's continuous employment until the applicable vesting date.

/s/ Cristina Paradiso, attorney-in-fact for Lee B. McChesney


Common Stock - Voting

Each share of phantom stock represents the right to receive one share of Common Stock - Voting.  Shares of Phantom Stock are payable in shares of Common Stock - Voting in accordance with the terms of the Non-Qualified Retirement Savings Plan.


Common Stock - Voting


Common Stock

Common Stock

These options vest in four equal annual installments beginning one year after the date of grant.

These options vest in four equal annual installments beginning one year after the 10/31/2022 date of grant.


Common Stock

Each restricted stock unit is convertible into a share of common stock on a 1-for-1 basis. The restricted stock units vested in common stock on August 9, 2025.

Includes shares acquired pursuant to the Company's Employee Stock Purchase Plan.

Shares withheld by the Company to satisfy tax withholding requirements.

These restricted stock units remain subject to a time-vesting requirement and are scheduled to vest and settle in common stock as follows: one-third of these restricted stock units vested on August 9, 2025, one-third of these restricted stock units vest on August 9, 2026 and the remaining one-third of these restricted stock units vest on August 9, 2027, assuming continued employment through the applicable vesting date.


Jane R. Grimm, Attorney-in-fact, for Amy A. Samford, Executive VP, Finance


Shares were purchased within the Issuer's Non-Qualified Stock Purchase Plan.


Common Stock, par value $0.001 per share

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, dated November 13, 2024.

Reflects the weighted average sale price. The highest price at which shares were sold was $26.80 and the lowest price at which shares were sold was $26.25. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

This amount includes 114,601 shares of restricted common stock subject to vesting and certain other restrictions.


William G. Kistner Trust Date June 22, 1973

/s/ Thomas J. Bell III, Attorney-in-Fact


Represents weighted average price.

Mr. Shaw has investment power over 500,000 shares as Trustee for the benefit of a family member. Mr. Shaw has voting control over the remainder of the shares pursuant to a voting agreement.

The Rule 10b5-1 Plan's date of adoption was August 22, 2024.


This figure does not include 101,394 shares held directly by Mr. Stahl.

For each indirect account, Mr. Stahl disclaims beneficial ownership except to the extent of his pecuniary interest, if any.


On December 18, 2024, Horizon Kinetics Asset Management LLC (HKAM) filed an amendment to its Schedule 13D, in which it noted beneficial ownership of 3,578,173 shares and Murray Stahl's direct interest in 7,848 shares and his indirect interest in approximately 156,083 shares. The extent of HKAM's pecuniary interest in the shares beneficially owned is disclosed herein. Mr. Stahl does not exercise investment discretion with respect to the securities of the Issuer.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

This option is 100% vested.

This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.

These restricted stock units convert into shares of common stock on a 1-for-1 basis.

These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.

Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.


Lisette and Michael Farrell Family Trust

ResMed Common Stock

The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.

This transaction was executed in multiple trades at prices ranging from $277.76 - $282.66. The price reported above reflects the weighted average sale price.

Represents date options first become exercisable. Options vest 1/3 per year.

Michael J. Farrell, Chief Executive Officer


/s/ Victor L. Cangelosi, pursuant to power of attorney


Common Shares, $2 par value per share

Common shares, $2 par value

Common Shares, $2 par value per share

On July 19, 2022, the reporting person was granted 2,500 stock options, of which 1,250 vested on July 19, 2023, 625 vested on July 19, 2024, and the remaining 625 vested on July 19, 2025. This transaction refers to the exercise of the last vested tranche of 625 shares at the option strike price.

Restricted stock units vest 3 years from the date of grant.

On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 will vest on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.

/s/ Caroline S Vaccariello, by power of attorney


Class B Common Stock

Class B Common Stock

This transaction was executed in multiple trades at prices ranging from $24.29 USD to $24.965 USD; the price reported above reflects the weighted average sale price.

This transaction was executed in multiple trades at prices ranging from $24.12 USD to $24.49 USD; the price reported above reflects the weighted average sale price.

These options vested in equal annual installments on each of the first four anniversaries of March 15, 2021.

In accordance with the provisions of the applicable plan and option agreements, the Compensation Committee approved an equitable adjustment to reduce the exercise price of the options from $22.04 at the time of the grant to $20.04 in order to reflect the $2.00 per share special dividend paid on outstanding shares of the Issuer's Class A and Class B common stock on November 9, 2020.

These options vested in equal annual installments on each of the first four anniversaries of March 15, 2020.


Common Stock

Common Stock

Restricted stock units convert into the Issuer's common stock on a one-for-one basis.

All of the restricted stock units will vest on August 8, 2026.

On August 9, 2024 the reporting person was granted 1,128 restricted stock units vesting on the first anniversary of the grant date.


Common Stock

Common Stock

These shares are held in a trust for the benefit of the reporting person, who also serves as sole trustee.


Common Stock

Common Stock


Common Stock


Ordinary shares, no par value

Ordinary shares, no par value

Restricted share units ("RSUs") converted into ordinary shares of the Company on a one-for-one basis upon vesting.

Represents shares withheld by the Company to cover tax withholding obligations upon vesting.

The RSUs do not expire.

Settlement of this award will be satisfied through the issuance of one ordinary share for each vested RSU.

Granted pursuant to the Capri Holdings Limited Fourth Amended and Restated Omnibus Incentive Plan. The RSUs vest on the earliest of: (1) the one year anniversary of the date of grant (August 7, 2026), or (2) the Company's annual shareholder meeting that occurs in the calendar year following the date of grant, and will be settled upon vesting unless the reporting person elects to defer settlement to a later date. If the reporting person's service with the Company terminates prior to the first anniversary of the date of grant, the RSUs will vest pro-rata based on the number of days from the date of grant through and including the date of the reporting person's termination of service. The RSUs will also vest in full in the event of the reporting person's death or disability.

/s/ Krista A. McDonough, as Attorney-in-Fact for Jean Tomlin


Ordinary shares, no par value

Ordinary shares, no par value

The RSUs do not expire.

/s/ Krista A. McDonough, as Attorney-in-Fact for Jane A. Thompson


Ordinary shares, no par value

Ordinary shares, no par value

The RSUs do not expire.

/s/ Krista A. McDonough, as Attorney-in-Fact for Stephen F. Reitman


by rabbi trust for Deferred Compensation Plan

Common shares, $2 par value

Common shares, $2 par value

Common shares, $2 par value

/s/ Caroline S. Vaccariello, by power of attorney


Ordinary shares, no par value

Ordinary shares, no par value

The RSUs do not expire.

/s/ Krista A. McDonough, as Attorney-in-Fact for Judy Gibbons


by rabbi trust for deferred compensation plan

/s/Caroline S. Vaccariello, by power or attorney


Ordinary shares, no par value

Ordinary shares, no par value

Restricted share units ("RSUs") converted into ordinary shres of the Company on a one-for-one basis upon vesting.

Represents shares withheld by the Company to cover tax withholding upon vesting.

The RSUs do not expire.

/s/ Krista A. McDonough, as Attorney-in-Fact for Robin Freestone


Common Stock, par value $0.0001 per share


Ordinary shares, no par value

Ordinary shares, no par value

The RSUs do not expire.

/s/ Krista A. McDonough, as Attorney-in-Fact for Mahesh Madhavan


Ordinary shares, no par value

Ordinary shares, no par value

The RSUs do not expire.

/s/ Krista A. McDonough, as Attorney-in-Fact for Marilyn Crouther


NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND


This price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.80 to $6.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

/s/ Lindsey Rhodes, by Power of Attorney


BLACKROCK CALIFORNIA MUNICIPAL INCOME TRUST


The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

Caroline Young by /s/ John Hamm as attorney-in-fact


Represents the automatic withholding by the issuer to satisfy the reporting person's tax obligation associated with the vesting of restricted stock units granted on August 7, 2024. This is authorized in the applicable restricted stock award agreement.


James Jones by /s/ John Hamm as attorney-in-fact


The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 464 shares is from $218.53 to $219.50. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.

The shares reported include 9,455 shares of restricted stock subject to vesting conditions.

The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 136 shares is from $219.53 to $219.94. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.

Michael G. Andrews under POA for the benefit of Annette N. Fritsch


Common Stock, par value $0.0001

Common Stock, par value $0.0001

Reflects shares issued upon the exercise of publicly-traded warrants (the Warrants) by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which the Reporting Person is a trustee and has voting
and dispositive power over the shares. The Warrants were distributed by the Issuer on July 21, 2025, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of
$8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the Warrant Agreement).

The shares and Warrants are held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which the Reporting Person is a trustee and has voting and dispositive power over the shares and Warrants.

The shares and Warrants are held by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares and
Warrants.

Includes 22,543 shares issuable upon the settlement of restricted stock units (RSUs) granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

The Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the Expiration Date). The Expiration Date is subject to automatic acceleration upon satisfaction
of the early expiration price condition (as defined in the Warrant Agreement) and subject to the other terms of the Warrant Agreement.

The Warrants were distributed by the Issuer on July 21, 2025, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Thurman J. Rodgers


A.J. Kazimi by /s/ John Hamm as attorney-in-fact


Reflects shares issued to the Reporting Person upon the exercise of publicly-traded warrants ("Warrants"). The Warrants were distributed by the Issuer on July 21, 2025, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the Warrant Agreement).

Includes 1,895,306 shares issuable upon the settlement of RSUs granted to the Reporting Person.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Raj Talluri


By: /s/ Daniel M. Bauer, as attorney-in-fact


Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact


Common Stock

Represents shares exchanged under an Exchange Agreement dated August 8, 2025 (the "Exchange Agreement") pursuant to which Mr. Kavanaugh exchanged 240,004 shares of common stock, par value $0.01 per share (the "Common Stock") of Medalist Diversified REIT, Inc. (the "Company"), on a one-for-one basis for 240,004 units of limited partnership interest (the "OP Units") in the Company's operating partnership, Medalist Diversified Holdings, LP (the "Operating Partnership").

Represents shares exchanged subject to the Exchange Agreement pursuant to which Mr. Kavanaugh exchanged 240,004 shares of Common Stock, on a one-for-one basis for 240,004 OP Units.

OP Units are redeemable for cash or, at the Company's option, shares of Common Stock, on a one-for-one basis after a holding period of one-year from the date of the Exchange Agreement.

Represents OP Units received subject to the Exchange Agreement pursuant to which Mr. Kavanaugh exchanged 240,004 shares of Common Stock on a one-for-one basis for 240,004 OP Units.

No expiration date.

On August 8, 2025, the Reporting Person exchanged 240,004 shares of Common Stock for 240,004 OP Units.


Does not include 3,847,046 shares of common stock held by trusts established by Reporting Person, of which Reporting Person disclaims beneficial ownership.


Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for the purchase and relinquishment of Non-Qualified Stock Options held by the Reporting Person.


Represents a grant of shares of PetVivo Holdings, Inc. restricted common stock ("Shares") to the Reporting Person as compensation for the purchase and relinquishment of warrant shares held by the Reporting Person.


Debra Tate Johnson, by Power of Attorney


Reflects an open market purchase of 7,000 of the Issuer's Chess Depositary Interests ("CDIs") on August 8, 2025 (Australia)/August 7, 2025 (U.S.). CDIs are units of beneficial ownership in shares of common stock of the Company that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty. Limited, a subsidiary of ASX Limited, the company that operates the ASX. Each CDI represents one fully paid share of common stock.  The transaction was executed in multiple block trades at prices ranging from $78.41 to $78.94. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.

Reflects an open market purchase of 1,275 of the Issuer's CDIs on August 8, 2025 (Australia)/August 7, 2025 (U.S.).  The transaction was executed in multiple block trades at prices ranging from $79.19 to $79.50. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.

Price converted from Australian dollars into U.S. Dollars based on an exchange rate of $1 AUD to $0.6527 USD.

Represents shares of common stock held by New Dusk Pty Ltd (Odell Family Trust), of which Mr. Odell serves as a director and a shareholder and is a beneficiary of the trust.

Represents shares of common stock held by the Jamie and Caroline Odell Superannuation Fund, a fund of which Mr. Odell is the beneficiary.

/s/ James Sottile, attorney-in-fact for Jamie Odell


See Exhibit 99.1.


Common Stock

Represents the conversion upon vesting of restricted stock units into common stock on August 8, 2025. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person.

/s/ Norman Roth Attorney-In-Fact for Cameron Munter


Common Stock

/s/ Norman Roth Attorney-In-Fact for Anne Busquet


Common Stock

/s/ Norman Roth Attorney-In-Fact for John Daly


Common Stock

/s/ Norman Roth Attorney-In-Fact for Bill Korn


Disposition effected by Goldman Sachs & Co. LLC pursuant to a previously established Rule 10b5-1 plan

Common stock held indirectly by entities controlled by the reporting person.


Common Stock

/s/ Norman Roth Attorney-In-Fact for Lawrence S. Sharnak


These shares were awarded as part of the Company's compensation program for non-management directors in connection with the 2025 annual stockholders' meeting.


Class A Common Stock

This option represents a right to purchase 11,504 shares of the Issuer's Class A Common Stock, which will vest and become exercisable in three equal annual installments following August 6, 2025, subject to the Reporting Person's continued service through each applicable vesting date.

/s/ Shawn M. Soderberg, as attorney-in-fact


Represents an award of restricted stock units, pursuant to a special award granted to the Reporting Person in connection with the terms of his new employment agreement entered into with the Issuer, effective August 5, 2025. The restricted stock units will vest in three equal annual installments of 1/3 each, on each of the first three anniversaries of August 5, 2025, subject to the Reporting Person's continued service.

Represents an award of restricted stock units, pursuant to a special award granted to the Reporting Person in connection with the terms of his new employment agreement entered into with the Issuer, effective August 5, 2025. The restricted stock units will vest in two equal annual installments of 1/2 each, on each of the fourth and fifth anniversaries of August 5, 2025, subject to the Reporting Person's continued service.

Chief Financial Officer-Designate The Reporting Person resigned as a member of the Company's Board of Directors, effective as of August 5, 2025, and has been appointed as the Company's Chief Financial Officer, effective as of September 1, 2025. As a result, the Reporting Person is voluntarily reporting these transactions on Form 4.

/s/ Jordan Frankel, Attorney-in-Fact for Christopher Nestor Cruz